Physician profile
Veena Mathur
NPI 1346390952
$1,542.91
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.61 · 2020: $17.50 · 2021: $83.26 · 2022: $122 · 2023: $1,136 · 2024: $86.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,115 · Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,115.26 |
| Food and Beverage | $107.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Canon Medical Systems USA, INC. | $1,115.26 | 2023 | Toshiba Scanner |
| Hologic INC | $80.86 | 2019 | |
| Siemens Medical Solutions USA, INC. | $49.71 | 2020-2022 | |
| Ge Healthcare | $39.89 | 2021-2022 | |
| Seagen INC. | $32.65 | 2022 | |
| Progenics Pharmaceuticals, INC. | $31.90 | 2024 | |
| Novartis Pharmaceuticals Corporation | $29.79 | 2024 | |
| Celgene Corporation | $24.52 | 2024 | Reblozyl |
| Eisai INC. | $22.50 | 2022 | |
| Blue Earth Diagnostics | $21.04 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $18.03 | 2021 | |
| Taiho Oncology, INC. | $17.03 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $16.75 | 2019 | |
| Emd Serono, INC. | $16.19 | 2022 | |
| Coherus Oncology, INC. | $14.47 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $12.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veena Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.